✦ LIBER ✦

Docetaxel-vinorelbine combination for platinum resistant paclitaxel pretreated ovarian cancer. A hellenic co-operative oncology group phase II study

✍ Scribed by G. Aravantinos; D. Bafaloukos; M.A. Dimopoulos; C. Nikolaides; P. Papakostas; Ch. Kiamouris; K. Sikiotis; T. Rapsomaniki; G. Fountzilas; D.V. Skarlos

Book ID: 117667896
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 159 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81357-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel in platin

A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study

✍ G. Aravantinos; D.V. Skarlos; P. Kosmidis; A. Athanassiades; D. Bafaloukos; T. G 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Paclitaxel in recurrent ovarian cancer:

Paclitaxel in recurrent ovarian cancer: Better upfront? Comments on: A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study. EurJ Cancer 1977, 33, 160–163.

✍ V.R. Bulusu 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 241 KB

0187 Weekly docetaxel with or without ge

0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

✍ F. Zagouri; A. Bamias; P. Papakostas; A. Karadimou; E. Bournakis; M. Dimopoulos; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Paclitaxel in combination with carboplat

Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study

✍ Kentepozidis, N.; Soultati, A.; Giassas, S.; Vardakis, N.; Kalykaki, A.; Kotsaki 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 254 KB

A randomized phase II study of carboplat

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

✍ Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimit 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 332 KB

Phase II trial of weekly paclitaxel (80

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

✍ Maurie Markman; John Blessing; Stephen C. Rubin; Joseph Connor; Parviz Hanjani; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 97 KB